News - AEterna Zentaris


Current filters:

AEterna Zentaris

Popular Filters

AEterna Zentaris transfers Cetrotide rights to Merck KGaA


Canada's AEterna Zentaris (TSX: AEZ) says that its German subsidiary has entered into binding agreements…

AEterna ZentarisCetrotideLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

Briefs: Eddingpharm deal with GSK China for Tykerb; AEterna Zentaris and Ergomed link on AEZS-108


Chinese drugmaker Eddingpharm has entered into a collaboration agreement with UK pharma giant GlaxoSmithKline's…

AEterna ZentarisAEZS-108Asia-PacificErgomed Clinical ResarchGlaxoSmithKlineLicensingOncologyPharmaceuticalResearchTykerb

AEterna Zentaris slides as it discontinues perifosine in myeloma


Canada's AEterna Zentaris (TSX: AEZ) saw its stock plunge as much as 29% (closing down 22.3% at C$2.09),…

AEterna ZentarisOncologyperifosinePharmaceuticalResearch

AEterna Zentaris' perifosine seen as potential novel approach for mesothelioma


Canada-based AEterna Zentaris (TSX: AEZ) has highlighted an article published in the May 2012 issue of…

AEterna ZentarisOncologyperifosinePharmaceuticalResearch

AEterna Zentaris and Keryx shares tank as cancer drug flops in Ph III


Canadian drug developer AEterna Zentaris (TSX: AEZ) and US licensee Keryx Pharmaceutical (Nasdaq: KERX)…

AEterna ZentarisKeryx BiopharmaceuticalsLicensingNephrology and HepatologyOncologyperifosinePharmaceuticalResearchZerenex

Highlights of ASH meeting


Among presentations at this year’s Annual Meeting of the American Society of Hematology (ASH), held…

AEterna ZentarisAriad PharmaceuticalsBiotechnologyblinatumomabMicrometOncologyperifosinePharmaceuticalPharmacyclicsponatinibResearch

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region


Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Back to top